SCHEMBL31060741

SCHEMBL31060741

O=C1Nc2ccccc2C1=Cc1sccc1Br

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 1.00
RAF1 P04049 1/20 0.56
PLK4 O00444 2/20 0.54
PLK1 P53350 2/20 0.54
RET P07949 4/20 0.51
EGFR P00533 1/20 0.51
CTRC Q99895 1/20 0.51
FLT3 P36888 3/20 0.50
PDGFRB P09619 3/20 0.50
JAK3 P52333 2/20 0.50
SYK P43405 1/20 0.50
ATM Q13315 1/20 0.50
MAP3K7 O43318 1/20 0.50
TAB1 Q15750 1/20 0.50
NPC1 O15118 1/20 0.50
CHEK1 O14757 1/20 0.50
AURKA O14965 1/20 0.50
DAPK3 O43293 1/20 0.50
PRKD3 O94806 1/20 0.50
MAP4K4 O95819 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6001467 1.00 KDR (1.00) KDRRAF1PLK4PLK1RET
SCHEMBL5727509 0.83 KDR (0.71) KDRPLK4PLK1RETEGFR
SCHEMBL5727507 0.83 KDR (0.71) KDRPLK4PLK1RETEGFR
SCHEMBL5988992 0.81 KDR (0.68) KDRRAF1JAK3CDK5TLK2
SCHEMBL5988086 0.81 KDR (0.68) KDRRAF1CDK5TLK2MAPT
SCHEMBL5988900 0.79 KDR (0.64) KDRRAF1RETJAK3SYK
SCHEMBL5374098 0.76 KDR (0.61) KDRRAF1PLK4PLK1EGFR
SCHEMBL5364548 0.75 KDR (0.59) KDRPDGFRBSYKAURKANTRK1
SCHEMBL3754999 0.75 KDR (0.69) KDRPLK4PLK1RETEGFR
SCHEMBL3754998 0.75 KDR (0.69) KDRPLK4PLK1RETEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4662319-A2 PERSONALIZED CRISPR PROFILING FOR CANCER Integrate Bioscience LLC (US) 2025-12-17 EP disclosed
WO-2024168301-A2 PERSONALIZED CRISPR PROFILING FOR CANCER FUNCTION ONCOLOGY, INC. (US) 2024-08-15 WO disclosed